IP Library Granted Patent US 9,656,999
Granted Patent B2
US 9,656,999 · App. 15/337,683 · Granted May 23, 2017

Therapeutically active compounds and their methods of use

Inventors: Giovanni Cianchetta (Waltham, MA); Byron DeLaBarre (Arlington, MA); Janeta Popovici-Muller (Waltham, MA); Francesco G. Salituro (Marlborough, MA); Jeffrey O. Saunders (Lincoln, MA); Jeremy Travins (Southborough, MA); Shunqi Yan (Irvine, CA); Tao Guo (Dayton, NJ); Li Zhang (Shanghai, CN)
Assignee: Agios Pharmaceuticals, Inc.
C07D401/14A61K31/53C07D251/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,656,999
App. No.
15/337,683
Granted
May 23, 2017
Kind
B2
Abstract

Provided are compounds useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound described herein.

Claims (5)

1. A method of synthesizing

comprising reacting 1-[4-chloro-6-(6-trifluoromethylpyridin-2-yl)-[1,3,5]triazin-2-ylamino]-2-methylpropan-2-ol with 2-trifluoromethylpyridin-4-ylamine in the presence of sodium tert-butoxide and Pd(dppf)Cl 2 .

2. The method of claim 1 , wherein the 1-[4-chloro-6-(6-trifluoromethylpyridin-2-yl)-[1,3,5]triazin-2-ylamino]-2-methylpropan-2-ol is synthesized by a method comprising reacting 2,4-dichloro-6-(6-trifluoromethylpyridin-2-yl)-1,3,5-triazine with 2-hydroxy-2-methyl-1-propylamine.

3. The method of claim 2 , wherein the 2,4-dichloro-6-(6-trifluoromethylpyridin-2-yl)-1,3,5-triazine is synthesized by a method comprising reacting 6-(6-trifluoromethylpyridin-2-yl)-1H-1,3,5-triazine-2,4-dione with POCl 3 and PCl 5 .

4. The method of claim 3 , wherein the 6-(6-trifluoromethylpyridin-2-yl)-1H-1,3,5-triazine-2,4-dione is synthesized by a method comprising reacting 6-trifluoromethylpyridine-2-carboxylic acid methyl ester with biuret in the presence of Na in ethanol.

Assignments (7)
CORRECTIVE ASSIGNMENT TO CORRECT THE THE ASSIGNEE NAME AND THE POSTAL CODE PREVIOUSLY RECORDED AT REEL: 056756 FRAME: 0459. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Mar 16, 2022
From: AGIOS PHARMACEUTICALS, INC.
To: SERVIER PHARMACEUTICALS LLC
Reel/Frame 059907/0429 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2021
From: AGIOS PHARMACEUTICALS, INC.
To: SERVIER PHARMACEUTICALS, LLC
Reel/Frame 056756/0459 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2017
From: WUXI APPTEC CO., LTD.
To: AGIOS PHARMACEUTICALS, INC.
Reel/Frame 043025/0462 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2017
From: CIANCHETTA, GIOVANNI; DELABARRE, BYRON; POPOVICI-MULLER, JANETA; SALITURO, FRANCESCO G.; SAUNDERS, JEFFREY O.; TRAVINS, JEREMY
To: AGIOS PHARMACEUTICALS, INC.
Reel/Frame 043025/0358 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2017
From: SCHRÖDINGER, LLC
To: AGIOS PHARMACEUTICALS, INC.
Reel/Frame 043025/0906 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2017
From: YAN, SHUNQI
To: SCHRÖDINGER, LLC
Reel/Frame 043025/0833 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2017
From: GUO, TAO; ZHANG, LI
To: WUXI APPTEC CO., LTD.
Reel/Frame 043025/0407 →
Continuity (4)
Continuation 15173519 · Jun 3, 2016
Continuation 13735467 · Jan 7, 2013
Provisional Application 61584214 · Jan 6, 2012
Related Publication 20170044139A1 · Feb 16, 2017